Viewing Study NCT02103569


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2025-12-28 @ 2:44 AM
Study NCT ID: NCT02103569
Status: COMPLETED
Last Update Posted: 2014-08-15
First Post: 2014-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module